subject: CHEBI:34967

object_name: schizoaffective disorder


subject: CHEBI:34967

subject_name: Rimonabant

object_name: schizophrenia 18

tested_intervention: yes


subject: CHEBI:34967

object_name: hypertension


subject: CHEBI:34967

object_name: Hypertension, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5315077

subject_name: TILMANOCEPT

object_name: Metastatic malignant neoplasm to liver


subject: CHEMBL.COMPOUND:CHEMBL5315077

object_name: colorectal carcinoma


subject: UNII:41XGO0VS1U

object_name: differentiated thyroid carcinoma


subject: UNII:807ME4B7IJ

subject_name: SELUMETINIB SULFATE

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7

tested_intervention: unsure


subject: UNII:807ME4B7IJ

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:807ME4B7IJ


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: cardiac allograft vasculopathy


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Neck Carcinoma


subject: CHEBI:8228

object_name: head and neck neoplasm


subject: CHEBI:8228

object_name: head and neck cancer


subject: DRUGBANK:DB17743

subject_name: Fecal microbiota

object_name: Clostridium difficile colitis


subject: DRUGBANK:DB17743

object_name: clostridium difficile infection


subject: CHEBI:6532

subject_name: Loperamide


subject: CHEBI:6532


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C0002525

subject_name: Amino Acids, Essential

object_name: Sarcopenic obesity


subject: CHEBI:4893

subject_name: ethyl acetoacetate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:4893

object_name: obesity


subject: CHEBI:4893

object_name: Obesity, CTCAE


subject: UMLS:C0243046

subject_name: Excitatory Amino Acids


subject: UMLS:C0243046


subject: UMLS:C0243046


subject: UMLS:C3888350

object_name: Carcinoma breast stage IV


subject: CHEBI:32682

subject_name: L-argininium

object_name: thalassemia


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Cutaneous neurofibroma


subject: CHEBI:36704

object_name: neurofibromatosis 1


subject: CHEBI:36704

object_name: neurofibromatosis type 1


subject: PUBCHEM.COMPOUND:10195332

object_name: chronic obstructive pulmonary disease


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: cold urticaria


subject: UMLS:C0910794


subject: MESH:C000621521

subject_name: Entoban

object_name: chronic diarrheal disease


subject: UNII:L500PR95QA


subject: CHEBI:6909


subject: UMLS:C0376560

subject_name: Recombinant Growth Hormone

object_name: hypopituitarism


subject: UMLS:C0376560

object_name: Hypopituitarism, CTCAE


subject: UMLS:C0376560

object_name: Congenital IGHD


subject: UMLS:C0376560

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C0376560

object_name: pituitary tumor


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:474053

subject_name: Cefazolin

object_name: osteoarthritis


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650387

object_name: prostate cancer


subject: UMLS:C0935953

subject_name: Mobist


subject: UMLS:C0935953


subject: UMLS:C4526709

subject_name: Personalized Genomic Vaccine 001


subject: UMLS:C4526709


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Chronic Bacterial Prostatitis


subject: CHEBI:150712

object_name: prostatitis


subject: CHEBI:150712

object_name: prostate disorder


subject: CHEBI:84040

object_name: endometriosis


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:7983

subject_name: Pentobarbital

object_name: traumatic encephalopathy


subject: CHEBI:7983

object_name: traumatic brain injury


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Withdrawal


subject: CHEBI:59112

object_name: Low back pain


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEMBL.COMPOUND:CHEMBL3989979

subject_name: RIVOGENLECLEUCEL

object_name: childhood acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: acute lymphoblastic leukemia


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: sickle cell disease


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: inborn error of immunity


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: Diamond-Blackfan anemia


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: lymphoma, non-Hodgkin, familial


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: inherited hemoglobinopathy


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: hemoglobinopathy


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: aplastic anemia


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: Fanconi anemia


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: Fanconi anemia complementation group A


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: thalassemia


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: Cytopenia


subject: CHEBI:15365

subject_name: Aspirin

object_name: ankylosis


subject: CHEBI:6129

subject_name: Ketorolac


subject: UMLS:C2719661

subject_name: influenza virus vaccine trivalent 2009-2010

object_name: influenza


subject: UNII:1B8447E7YI

subject_name: CLOMIPHENE CITRATE

object_name: uterine fibroid


subject: CHEBI:3752

subject_name: Clomifene


subject: UMLS:C5855043

subject_name: Technetium Tc-99m-MIRC213

object_name: Childhood Breast Carcinoma


subject: UMLS:C5855043

object_name: breast carcinoma


subject: UMLS:C5855043

object_name: breast cancer


subject: UMLS:C1883695

subject_name: Opioid Agonist [EPC]

object_name: Marijuana Usage


subject: UMLS:C2347652

subject_name: Povidone-Iodine Solution

object_name: pleural empyema


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:18319735

object_name: Malignant myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:18319735

object_name: essential thrombocythemia


subject: PUBCHEM.COMPOUND:18319735

object_name: acquired polycythemia vera


subject: PUBCHEM.COMPOUND:18319735

object_name: myelofibrosis


subject: CHEBI:233436

subject_name: Tolebrutinib

object_name: Decreased liver function


subject: DRUGBANK:DB18715


subject: CHEMBL.COMPOUND:CHEMBL4297797

object_name: EXCESS LMW-DNA


subject: UMLS:C5853357


subject: UMLS:C5203412

subject_name: Midazolam Liquid Injection

object_name: Pain Disorder


subject: CHEBI:6931

subject_name: Midazolam


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: intestinal obstruction


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: hairy cell leukemia


subject: CHEBI:91397

object_name: HCL-V


subject: CHEBI:91397

object_name: Recurrent Hairy Cell Leukemia Variant


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: age related macular degeneration 1


subject: UNII:QC4F7FKK7I

object_name: choroidal neovascularization


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: Inappropriate sinus tachycardia


subject: UMLS:C0001645

object_name: Inappropriate Sinus Tachycardia by ECG Finding


subject: UNII:C8ADC441ME

subject_name: Ivabradine


subject: UNII:C8ADC441ME


subject: UNII:2158753C7E

subject_name: Relacorilant

object_name: Hepatic impairment


subject: MESH:D005232

subject_name: Fatty Acids, Volatile

object_name: abdominal obesity-metabolic syndrome


subject: MESH:D005232

object_name: metabolic syndrome X


subject: CHEBI:177416

subject_name: Pexacerfont

object_name: anxiety disorder


subject: CHEBI:177416

object_name: alcohol abuse


subject: CHEBI:177416

object_name: alcohol dependence


subject: CHEBI:177416

object_name: alcohol-related disorders


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: lichen planus, oral


subject: UMLS:C5706351

subject_name: ABL 202

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706351

object_name: Advanced Lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:74705

subject_name: Met-Leu

object_name: cancer-related condition


subject: CHEBI:74705

object_name: Depressive Symptoms


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PUBCHEM.COMPOUND:54676860

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:54676860

object_name: Brain Stem Glioblastoma


subject: PUBCHEM.COMPOUND:54676860

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:54676860

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:54676860

object_name: adult glioblastoma


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:22651

subject_name: ascorbate


subject: CHEBI:22651


subject: CHEBI:22651


subject: CHEBI:22651


subject: CHEBI:22651


subject: CHEBI:167715

subject_name: L-ascorbic acid 2-sulfate


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:167715


subject: MESH:C423724

subject_name: Biafine

object_name: actinic keratosis


subject: RXCUI:93814

subject_name: polysporin ointment


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Premature Labor


subject: CHEBI:50731

object_name: Latent Phase of Labor


subject: CHEBI:50731

object_name: Labor Pain


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:8461

subject_name: Promethazine


subject: CHEBI:8461


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: arteriosclerosis disorder


subject: CHEBI:169833

object_name: atherosclerosis


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:82814


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:101278


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates

object_name: hemophilia B


subject: UMLS:C0072434

object_name: hemophilia B leyden


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN

object_name: Deep Venous Thrombosis Related to COVID-19


subject: CHEBI:87715

subject_name: Prasugrel

object_name: Platelet thrombus


subject: CHEBI:87715

object_name: Hemorrhage


subject: CHEBI:76842

object_name: reported history of cataract surgery


subject: CHEBI:76842

object_name: endophthalmitis


subject: CHEBI:76842

object_name: Endophthalmitis, CTCAE


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:177764

subject_name: Perzinfotel

object_name: Diabetic Neuralgia


subject: CHEBI:177764

object_name: diabetes mellitus


subject: DRUGBANK:DB10769

subject_name: Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)

object_name: dengue disease


subject: DRUGBANK:DB10769

object_name: Severe Dengue


subject: UMLS:C0771080

subject_name: Japanese Encephalitis Vaccines


subject: UMLS:C0771080


subject: UMLS:C3714691

subject_name: Japanese B encephalitis vaccine (product)


subject: UMLS:C3714691


subject: UMLS:C5706429

subject_name: KRAS G12C Inhibitor HS-10370

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: Tako-tsubo cardiomyopathy


subject: UMLS:C0001645

object_name: cardiovascular surgery result: left ventricular function


subject: UMLS:C5706349

subject_name: SRF 813

object_name: neoplasm


subject: UMLS:C4722537

subject_name: TG02 Citrate

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:149504

object_name: Decreased cardiac output


subject: CHEBI:149504

object_name: congestive heart failure


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: end stage renal failure


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: lichen planus, oral


subject: UNII:9A54BAZ0YA

object_name: multiple sclerosis


subject: UMLS:C3713697


subject: UNII:KL7B6D38VC

subject_name: LARTESERTIB

object_name: ovarian cancer


subject: UNII:KL7B6D38VC

object_name: ovarian neoplasm


subject: UNII:KL7B6D38VC

object_name: ovarian carcinoma


subject: DRUGBANK:DB19045

subject_name: Lartesertib


subject: DRUGBANK:DB19045


subject: DRUGBANK:DB19045


subject: UMLS:C5556287

subject_name: ATM Kinase Inhibitor M4076


subject: UMLS:C5556287


subject: UMLS:C5556287


subject: PUBCHEM.COMPOUND:90199447

subject_name: TUVUSERTIB


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UMLS:C5417840

subject_name: ATR Kinase Inhibitor M1774


subject: UMLS:C5417840


subject: UMLS:C5417840


subject: GTOPDB:3545

subject_name: urocortin 2

object_name: heart disorder


subject: GTOPDB:3545

object_name: aneurysm


subject: UMLS:C0969397

subject_name: urocortin II


subject: UMLS:C0969397


subject: GTOPDB:928

subject_name: urocortin 3


subject: GTOPDB:928


subject: UMLS:C0967953

subject_name: urocortin III


subject: UMLS:C0967953


subject: CHEBI:3374

subject_name: Capsaicin

object_name: postherpetic neuralgia


subject: CHEBI:3374

object_name: peripheral nerve injury


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: Thrombosis of blood vessel


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:6801

subject_name: Metformin

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: Urinary Bladder, Underactive


subject: CHEBI:8665

object_name: benign prostatic hyperplasia


subject: CHEMBL.COMPOUND:CHEMBL4297914

subject_name: TALDEFGROBEP ALFA

object_name: spinal muscular atrophy


subject: CHEMBL.COMPOUND:CHEMBL4297914

object_name: proximal spinal muscular atrophy


subject: CHEMBL.COMPOUND:CHEMBL4297914

object_name: neuromuscular disease


subject: CHEMBL.COMPOUND:CHEMBL4297914

object_name: Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma


subject: UMLS:C5238197

subject_name: Talditercept alfa


subject: UMLS:C5238197


subject: UMLS:C5238197


subject: UMLS:C5238197


subject: CHEBI:94771

subject_name: Quisinostat

object_name: uveal melanoma


subject: CHEBI:9635

subject_name: Toremifene


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: Metastatic Malignant Solid Neoplasm


subject: DRUGBANK:DB17860

object_name: sickle cell disease


subject: DRUGBANK:DB17860

object_name: sickle cell-hemoglobin c disease syndrome


subject: CHEBI:17290

subject_name: (S)-3-hydroxybutyric acid

object_name: Finding of blood glucose level


subject: CHEBI:17290

object_name: Ketosis


subject: CHEBI:17290

object_name: Ketoacidosis


subject: CHEBI:20067

subject_name: beta-Hydroxybutyric acid


subject: CHEBI:20067


subject: CHEBI:20067


subject: CHEBI:17066

subject_name: (R)-3-hydroxybutyric acid


subject: UMLS:C4279904

subject_name: Asmanex Twisthaler

object_name: asthma


subject: UNII:349552KRHK

subject_name: Simendan

object_name: Pelvis fracture


subject: UNII:349552KRHK

object_name: Hip Fracture, CTCAE


subject: UNII:349552KRHK

object_name: hip fracture


subject: UNII:349552KRHK

object_name: Abnormal left ventricular function


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: CHEBI:50567


subject: CHEBI:50567


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Plasma cell myeloma recurrent


subject: CHEBI:93775

object_name: plasma cell leukemia


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: intracerebral hemorrhage


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:230905

subject_name: Ribociclib


subject: UNII:TUK9QB44B0

object_name: immunoglobulin G4-related sclerosing disease


subject: UNII:TUK9QB44B0

object_name: Immunoglobulin G4-Related Disease


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: UMLS:C2351399


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: micropapillary serous carcinoma


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Pulmonary arterial hypertension associated with portal hypertension


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: DRUGBANK:DB10631

subject_name: Cranberry

object_name: Inflammation


subject: DRUGBANK:DB10631

object_name: Increased reactive oxygen species production


subject: DRUGBANK:DB10631

object_name: Chronic uremia


subject: UMLS:C0453273

subject_name: cranberry preparation


subject: UMLS:C0453273


subject: UMLS:C0453273


subject: CHEBI:9434

subject_name: Telmisartan

object_name: Mental deterioration


subject: CHEBI:9434

object_name: Cognitive impairment


subject: CHEBI:233408

subject_name: Olesoxime

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C2001395


subject: UNII:F8XAG1755S

subject_name: Borage oil

object_name: asthma


subject: CHEBI:9144

subject_name: Silibinin

object_name: HIV Seronegativity


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:132922

object_name: canker sore


subject: CHEBI:132922

object_name: Minor oral aphthous ulceration


subject: CHEBI:132922

object_name: aphthous stomatitis


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:74705

subject_name: Met-Leu

object_name: sinusitis


subject: CHEBI:74705

object_name: Sinusitis, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: DRUGBANK:DB17019


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: tumor of adipose tissue


subject: CHEBI:40237

subject_name: Sitagliptin


subject: UMLS:C5433403

subject_name: Forxiga

object_name: Prediabetes


subject: UMLS:C5433403

object_name: coronary artery disorder


subject: UMLS:C5433403

object_name: coronary atherosclerosis


subject: CHEBI:167574

subject_name: Semaglutide


subject: UMLS:C4522818

subject_name: NexIUM 24HR

object_name: digestive system disorder


subject: CHEBI:15365

subject_name: Aspirin

object_name: Heart Disease Risk Factors


subject: CHEBI:177298

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:177298

object_name: colon cancer


subject: CHEBI:177298

object_name: malignant urinary system neoplasm


subject: CHEBI:177298

object_name: melanoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Disorder of intraocular pressure


subject: PUBCHEM.COMPOUND:18319735

object_name: Intraocular Pressure


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: prostate carcinoma


subject: UNII:RZ22DI43TP

object_name: prostate cancer


subject: UNII:RZ22DI43TP

object_name: osteoarthritis, hip


subject: UNII:RZ22DI43TP

object_name: Disorder of knee


subject: UNII:RZ22DI43TP

object_name: spina bifida


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C0072434


subject: UMLS:C0072434


subject: UMLS:C0072434


subject: UMLS:C0072434


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UMLS:C4048712


subject: UMLS:C4048712


subject: UMLS:C4048712


subject: UMLS:C4048712


subject: CHEBI:177760

subject_name: Terbogrel

object_name: pulmonary hypertension


subject: UNII:6Q2L2H0POF

subject_name: DIMESNA

object_name: non-small cell lung carcinoma


subject: UMLS:C1707754

subject_name: Tavocept


subject: UMLS:C0752700


subject: UNII:25DT549L0G

object_name: HIV infection


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:63618

subject_name: Pravastatin

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:63618

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:63618

object_name: chronic myelomonocytic leukemia


subject: CHEBI:63618

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: stricture


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:7CND0TX59N

object_name: recurrent cutaneous T-cell lymphoma


subject: UNII:7CND0TX59N

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:7CND0TX59N

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:7CND0TX59N

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:7CND0TX59N

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: UNII:7CND0TX59N

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: UNII:7CND0TX59N

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: UNII:7CND0TX59N

object_name: adult lymphocyte predominant Hodgkin lymphoma


subject: UNII:7CND0TX59N

object_name: hepatosplenic T-cell lymphoma


subject: UNII:7CND0TX59N

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:7CND0TX59N

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:7CND0TX59N

object_name: anaplastic large cell lymphoma


subject: UNII:7CND0TX59N

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:7CND0TX59N

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UNII:7CND0TX59N

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UNII:7CND0TX59N

object_name: noncutaneous extranodal lymphoma


subject: UNII:7CND0TX59N

object_name: T-cell large granular lymphocyte leukemia


subject: UNII:7CND0TX59N

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:25646

subject_name: octanoate

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:25646

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:25646

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:25646

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:25646

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:25646

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: CHEBI:25646

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: CHEBI:25646

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: CHEBI:25646

object_name: adult lymphocyte predominant Hodgkin lymphoma


subject: CHEBI:25646

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:25646

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:25646

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:25646

object_name: anaplastic large cell lymphoma


subject: CHEBI:25646

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:25646

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:25646

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:25646

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:25646

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:25646

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:28837

subject_name: Caprylic acid

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:28837

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:28837

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:28837

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:28837

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:28837

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: CHEBI:28837

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: CHEBI:28837

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: CHEBI:28837

object_name: adult lymphocyte predominant Hodgkin lymphoma


subject: CHEBI:28837

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:28837

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:28837

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:28837

object_name: anaplastic large cell lymphoma


subject: CHEBI:28837

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:28837

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:28837

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:28837

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:28837

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:28837

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:135515

subject_name: Bendamustine


subject: CHEBI:135515


subject: CHEBI:135515


subject: UMLS:C3502775

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: pulmonary tuberculosis


subject: CHEBI:41423

subject_name: Celecoxib

object_name: thymoma


subject: CHEBI:41423

object_name: thymus neoplasm


subject: MESH:C097921

object_name: Childhood Breast Carcinoma


subject: MESH:C097921

object_name: breast carcinoma


subject: MESH:C097921

object_name: breast cancer


subject: CHEBI:50819

subject_name: Ferric oxide


subject: CHEBI:50819


subject: CHEBI:50819


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: Duchenne muscular dystrophy


subject: PUBCHEM.COMPOUND:3467

object_name: Becker muscular dystrophy


subject: MESH:D012739

subject_name: Gonadal Steroid Hormones

object_name: heart failure


subject: MESH:D012739

object_name: Atrial fibrillation and flutter


subject: MESH:D012739

object_name: Arrhythmia


subject: MESH:D012739

object_name: Supraventricular tachycardia


subject: GTOPDB:2448

object_name: periapical periodontitis


subject: GTOPDB:2448

object_name: dental pulp disorder


subject: CHEBI:16240

subject_name: Hioxyl


subject: PUBCHEM.COMPOUND:3370

subject_name: Fludrocortisone acetate

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:50885

subject_name: Fludrocortisone


subject: CHEBI:16962

subject_name: Cortisone


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: PUBCHEM.COMPOUND:135151902

subject_name: OPEVESOSTAT


subject: DRUGBANK:DB18818

subject_name: Opevesostat


subject: MESH:C000597235

object_name: HIV infection


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: CNS metastases


subject: PUBCHEM.COMPOUND:2269

object_name: shigellosis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Chronic liver disease


subject: CHEBI:60802

subject_name: ropivacaine

object_name: chronic kidney disease


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456

object_name: Chronic uremia


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: osteoarthritis, knee


subject: CHEBI:16796

subject_name: Melatonin


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: traumatic brain injury


subject: UMLS:C0879272

object_name: melanoma


subject: UMLS:C0879272

object_name: Childhood Solid Neoplasm


subject: UMLS:C0879272

object_name: Adult Solid Neoplasm


subject: UMLS:C0879272

object_name: Solid Neoplasm


subject: UMLS:C5226476

object_name: Erosive gastroesophageal reflux disease


subject: UMLS:C2987342

object_name: neuroendocrine neoplasm


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: peripheral vascular disease


subject: CHEBI:3215

object_name: peripheral arterial disease


subject: CHEBI:28262

subject_name: Dimethyl sulfoxide

object_name: Childhood Breast Carcinoma


subject: CHEBI:28262

object_name: breast carcinoma


subject: CHEBI:28262

object_name: breast cancer


subject: CHEBI:28262

object_name: radiodermatitis


subject: CHEBI:28262

object_name: Early radiation dermatitis


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: retinal ischemia


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Advanced Endometrial Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Advanced renal cell carcinoma


subject: UNII:52CMI0WC3Y

object_name: Advanced Malignant Abdominal Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Advanced Malignant Thoracic Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Advanced Malignant Female Reproductive System Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Advanced Fallopian Tube Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Metastatic Malignant Female Reproductive System Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Advanced Primary Peritoneal Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Metastatic Malignant Abdominal Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Malignant Abdominal Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Metastatic Malignant Thoracic Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Metastatic Endometrial Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Primary Peritoneal Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:52CMI0WC3Y

object_name: Metastatic Fallopian Tube Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Ovarian Carcinoma


subject: UMLS:C3827082

object_name: Advanced Endometrial Carcinoma


subject: UMLS:C3827082

object_name: Advanced renal cell carcinoma


subject: UMLS:C3827082

object_name: Advanced Malignant Abdominal Neoplasm


subject: UMLS:C3827082

object_name: Advanced Malignant Thoracic Neoplasm


subject: UMLS:C3827082

object_name: Advanced Malignant Female Reproductive System Neoplasm


subject: UMLS:C3827082

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Advanced Fallopian Tube Carcinoma


subject: UMLS:C3827082

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: UMLS:C3827082

object_name: Metastatic Malignant Female Reproductive System Neoplasm


subject: UMLS:C3827082

object_name: Advanced Primary Peritoneal Carcinoma


subject: UMLS:C3827082

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3827082

object_name: Metastatic Malignant Abdominal Neoplasm


subject: UMLS:C3827082

object_name: Malignant Abdominal Neoplasm


subject: UMLS:C3827082

object_name: Metastatic Malignant Thoracic Neoplasm


subject: UMLS:C3827082

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C3827082

object_name: Metastatic Primary Peritoneal Carcinoma


subject: UMLS:C3827082

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C3827082

object_name: Metastatic Fallopian Tube Carcinoma


subject: UMLS:C3827082

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Advanced Endometrial Carcinoma


subject: CHEBI:72317

object_name: Advanced Malignant Abdominal Neoplasm


subject: CHEBI:72317

object_name: Advanced Malignant Thoracic Neoplasm


subject: CHEBI:72317

object_name: Advanced Breast Carcinoma


subject: CHEBI:72317

object_name: Advanced Malignant Female Reproductive System Neoplasm


subject: CHEBI:72317

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: CHEBI:72317

object_name: Advanced Fallopian Tube Carcinoma


subject: CHEBI:72317

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: CHEBI:72317

object_name: Metastatic Malignant Female Reproductive System Neoplasm


subject: CHEBI:72317

object_name: Advanced Primary Peritoneal Carcinoma


subject: CHEBI:72317

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:72317

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:72317

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:72317

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:72317

object_name: Metastatic Malignant Abdominal Neoplasm


subject: CHEBI:72317

object_name: Malignant Abdominal Neoplasm


subject: CHEBI:72317

object_name: Metastatic Malignant Thoracic Neoplasm


subject: CHEBI:72317

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:72317

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:72317

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:72317

object_name: Metastatic Fallopian Tube Carcinoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Advanced Endometrial Carcinoma


subject: MESH:C520255

object_name: Advanced renal cell carcinoma


subject: MESH:C520255

object_name: Advanced Malignant Abdominal Neoplasm


subject: MESH:C520255

object_name: Advanced Malignant Thoracic Neoplasm


subject: MESH:C520255

object_name: Advanced Malignant Female Reproductive System Neoplasm


subject: MESH:C520255

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: MESH:C520255

object_name: Stage III Renal Cell Cancer AJCC v8


subject: MESH:C520255

object_name: Advanced Hepatocellular Carcinoma


subject: MESH:C520255

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: MESH:C520255

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: MESH:C520255

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: MESH:C520255

object_name: Advanced Fallopian Tube Carcinoma


subject: MESH:C520255

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: MESH:C520255

object_name: Metastatic Malignant Female Reproductive System Neoplasm


subject: MESH:C520255

object_name: Advanced Primary Peritoneal Carcinoma


subject: MESH:C520255

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: MESH:C520255

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: MESH:C520255

object_name: Metastatic Malignant Abdominal Neoplasm


subject: MESH:C520255

object_name: Malignant Abdominal Neoplasm


subject: MESH:C520255

object_name: Metastatic Malignant Thoracic Neoplasm


subject: MESH:C520255

object_name: Metastatic Endometrial Carcinoma


subject: MESH:C520255

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: MESH:C520255

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: MESH:C520255

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: MESH:C520255

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: MESH:C520255

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: MESH:C520255

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: MESH:C520255

object_name: Metastatic Renal Cell Carcinoma


subject: MESH:C520255

object_name: Metastatic Renal Cell Cancer


subject: MESH:C520255

object_name: Metastatic Primary Peritoneal Carcinoma


subject: MESH:C520255

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: MESH:C520255

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Advanced Endometrial Carcinoma


subject: CHEBI:45863

object_name: Advanced renal cell carcinoma


subject: CHEBI:45863

object_name: Advanced Malignant Abdominal Neoplasm


subject: CHEBI:45863

object_name: Advanced Malignant Thoracic Neoplasm


subject: CHEBI:45863

object_name: Advanced Malignant Female Reproductive System Neoplasm


subject: CHEBI:45863

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:45863

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: CHEBI:45863

object_name: Advanced Fallopian Tube Carcinoma


subject: CHEBI:45863

object_name: Metastatic Malignant Female Reproductive System Neoplasm


subject: CHEBI:45863

object_name: Advanced Primary Peritoneal Carcinoma


subject: CHEBI:45863

object_name: Metastatic Malignant Abdominal Neoplasm


subject: CHEBI:45863

object_name: Malignant Abdominal Neoplasm


subject: CHEBI:45863

object_name: Metastatic Malignant Thoracic Neoplasm


subject: CHEBI:45863

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:45863

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:8772

subject_name: Raloxifene

object_name: Depressed mood


subject: CHEBI:8772

object_name: Cancer patients and suicide and depression


subject: CHEBI:8772

object_name: Depressed - symptom


subject: CHEBI:8772

object_name: Depression, CTCAE


subject: CHEBI:8772

object_name: Depression perimenopausal


subject: CHEBI:37845

subject_name: growth hormone

object_name: metabolic dysfunction-associated steatotic liver disease


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:94187

subject_name: Givinostat

object_name: myeloproliferative neoplasm


subject: CHEBI:3901

subject_name: Tetracosactide

object_name: Physiological Stress


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: UMLS:C5400115

object_name: Throat cancer


subject: UMLS:C5400115

object_name: head and neck cancer


subject: UMLS:C1095897

subject_name: Astragalus preparation

object_name: Parkinsonism


subject: CHEBI:181423

subject_name: CALCIFEDIOL

object_name: myocardial infarction


subject: CHEBI:181423

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:181423

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C3714609

subject_name: Calcifediol Drug Class


subject: UMLS:C3714609


subject: UMLS:C3714609


subject: CHEBI:17933

subject_name: Calcifediol


subject: CHEBI:17933


subject: CHEBI:17933


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Tonsillar hemorrhage


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Preterm Premature Rupture of Fetal Membranes


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C1519138

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:52010

subject_name: chlorphenamine

object_name: sunburn


subject: MESH:C000616023

subject_name: AS01B adjuvant

object_name: Plasmodium falciparum malaria


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: cancer of unknown primary site


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: central centrifugal cicatricial alopecia


subject: CHEBI:18258

subject_name: Liothyronine

object_name: Recurrent Childhood Gliosarcoma


subject: CHEBI:18258

object_name: Recurrent Gliosarcoma


subject: CHEBI:18258

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:18258

object_name: Recurrent Glioblastoma


subject: CHEBI:6520

subject_name: Lomustine


subject: CHEBI:6520


subject: CHEBI:50673

subject_name: Methimazole


subject: CHEBI:50673


subject: CHEBI:50673


subject: CHEBI:50673


subject: UMLS:C5783863

subject_name: Hpk1 Inhibitor NDI-101150

object_name: Childhood Solid Neoplasm


subject: UMLS:C5783863

object_name: Adult Solid Neoplasm


subject: UMLS:C5783863

object_name: Solid Neoplasm


subject: UMLS:C5783863

object_name: non-small cell lung carcinoma


subject: UNII:BKQ9CX6BRB


subject: UNII:BKQ9CX6BRB


subject: UNII:BKQ9CX6BRB


subject: UNII:BKQ9CX6BRB


subject: PUBCHEM.COMPOUND:71853

subject_name: Chitosan

object_name: Abnormal vaginal bleeding


subject: PUBCHEM.COMPOUND:71853

object_name: Vaginal Hemorrhage


subject: CHEBI:57704

subject_name: cationic chitosan


subject: CHEBI:57704


subject: CHEBI:16261

subject_name: chitosan


subject: CHEBI:16261


subject: UMLS:C5966113

subject_name: CDK8/19 Inhibitor RVU120

object_name: adult acute myeloid leukemia


subject: CHEBI:231342

subject_name: ceralasertib

object_name: Refractory Cholangiocarcinoma


subject: CHEBI:231342

object_name: Malignant Solid Neoplasm


subject: CHEBI:231342

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:6801

subject_name: Metformin

object_name: psoriasis


subject: CHEBI:95346

subject_name: Atovaquone


subject: UMLS:C0721124

subject_name: Iron Supplement

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0721124

object_name: obesity


subject: UMLS:C0721124

object_name: Obesity, CTCAE


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: UMLS:C0003442

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: UMLS:C0003442

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: UMLS:C0003442

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: UMLS:C0003442

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:61057

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:61057

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:61057

object_name: adult acute monocytic leukemia


subject: CHEBI:61057

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:230016

object_name: head and neck neoplasm


subject: CHEBI:230016

object_name: bladder tumor


subject: CHEBI:230016

object_name: breast neoplasm


subject: CHEBI:230016

object_name: lung neoplasm


subject: CHEBI:36946

subject_name: thiourea


subject: CHEBI:36946


subject: CHEBI:36946


subject: CHEBI:36946


subject: CHEBI:134726

subject_name: Istradefylline

object_name: movement disorder


subject: UMLS:C0673472


subject: CHEBI:4911

subject_name: Etoposide

object_name: large B-cell lymphoma


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: opioid use


subject: PUBCHEM.COMPOUND:6012

object_name: Back Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:6012

object_name: Back pain


subject: PUBCHEM.COMPOUND:6012

object_name: Back Pain, CTCAE 3.0


subject: PUBCHEM.COMPOUND:6012

object_name: Androgen insufficiency


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:50838

subject_name: Drospirenone

object_name: postmenopausal osteoporosis


subject: CHEBI:50838

object_name: osteoporosis


subject: PR:000012938

subject_name: pinin


subject: PR:000012938


subject: PUBCHEM.COMPOUND:9874151

subject_name: Angeliq


subject: PUBCHEM.COMPOUND:9874151


subject: UMLS:C1455162


subject: UMLS:C1455162


subject: CHEBI:149504

object_name: liver carcinoma


subject: CHEBI:6541

subject_name: Losartan


subject: UNII:A2VM2V569A

object_name: pancreatic neoplasm


subject: UNII:A2VM2V569A

object_name: exocrine pancreatic carcinoma


subject: UNII:A2VM2V569A

object_name: malignant pancreatic neoplasm


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: COL6A3 Positive


subject: UNII:M89N0Q7EQR

object_name: PRAME Positive


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: GTOPDB:9244

subject_name: utomilumab

object_name: Recurrent ovarian cancer


subject: GTOPDB:9244

object_name: HLA-A*0201 Positive Cells Present


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: CHEMBL.COMPOUND:CHEMBL3707324

subject_name: UTOMILUMAB


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Headache


subject: CHEBI:7773

object_name: Headache, CTCAE


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Cirrhosis


subject: CHEBI:187893

subject_name: Baclofen

object_name: Hypertonia


subject: CHEBI:187893

object_name: primary dysautonomia


subject: CHEBI:187893

object_name: dysautonomia


subject: CHEBI:187893

object_name: autonomic nervous system disorder


subject: CHEBI:187893

object_name: traumatic encephalopathy


subject: CHEBI:187893

object_name: traumatic brain injury


subject: CHEBI:187893

object_name: Anoxia of brain


subject: CHEBI:187893

object_name: ocular motor apraxia, Cogan type


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C4724866

subject_name: Cyclin-dependent Kinase 8/19 Inhibitor BCD 115

object_name: Childhood Breast Carcinoma


subject: UMLS:C4724866

object_name: breast carcinoma


subject: UMLS:C4724866

object_name: breast cancer


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Recurrent Medulloblastoma


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Childhood Medulloblastoma


subject: PUBCHEM.COMPOUND:1805

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775

object_name: Recurrent Ependymoma


subject: CHEBI:93775

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C2355268

object_name: kidney cancer


subject: CHEBI:15365

subject_name: Aspirin

object_name: Platelet thrombus


subject: CHEBI:15365

object_name: Drug Metabolism, Poor, CYP2C19-Related


subject: CHEBI:15365

object_name: arterial occlusion


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941

object_name: aspirin sensitivity


subject: CHEBI:37941


subject: CHEBI:37941


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: inflammatory bowel disease 1


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: intracerebral hemorrhage


subject: UMLS:C2825026

object_name: Deep vein thrombosis of lower limb


subject: UMLS:C2825026

object_name: pulmonary embolism


subject: UMLS:C0873173

subject_name: red yeast rice extract

object_name: inherited lipid metabolism disorder


subject: MESH:C117343

subject_name: red yeast rice


subject: MESH:C117343

object_name: Dyslipidemia


subject: GTOPDB:9161

subject_name: ulocuplumab

object_name: Childhood Solid Neoplasm


subject: GTOPDB:9161

object_name: Adult Solid Neoplasm


subject: GTOPDB:9161

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3039543

subject_name: ULOCUPLUMAB


subject: CHEMBL.COMPOUND:CHEMBL3039543


subject: CHEMBL.COMPOUND:CHEMBL3039543


subject: UMLS:C2987400


subject: UMLS:C2987400


subject: UMLS:C2987400


subject: CHEBI:6904

subject_name: Metoprolol

object_name: aortic valve insufficiency


subject: GTOPDB:8357

subject_name: donanemab

object_name: Down syndrome


subject: UNII:1ADB65P1KK

subject_name: DONANEMAB


subject: UMLS:C5237999


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor

object_name: Hemorrhage


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: CHEBI:5779

subject_name: Hydrocodone

object_name: toothache


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: opsoclonus-myoclonus syndrome


subject: UNII:DWN2WN457X

object_name: Childhood Neuroblastoma


subject: UNII:DWN2WN457X

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: GTOPDB:4934

subject_name: G-CSF

object_name: infertility


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: mucosal melanoma


subject: CHEBI:72317

object_name: anal melanoma


subject: CHEBI:72317

object_name: Recurrent Mucosal Melanoma


subject: CHEBI:72317

object_name: Penile Mucosal Melanoma


subject: CHEBI:72317

object_name: vaginal melanoma


subject: CHEBI:72317

object_name: cutaneous undifferentiated pleomorphic sarcoma


subject: CHEBI:72317

object_name: Sinonasal Mucosal Melanoma


subject: CHEBI:72317

object_name: Rectal Melanoma


subject: CHEBI:72317

object_name: Oral Cavity Mucosal Melanoma


subject: CHEBI:72317

object_name: Urethral Melanoma


subject: CHEBI:72317

object_name: cervix melanoma


subject: CHEBI:72317

object_name: Nasopharyngeal Melanoma


subject: CHEBI:72317

object_name: esophageal melanoma


subject: CHEBI:72317

object_name: vulvar melanoma


subject: CHEBI:72317

object_name: Bladder Melanoma


subject: CHEBI:72317

object_name: gallbladder melanoma


subject: PUBCHEM.COMPOUND:9884233

subject_name: ALBUTEROL SULFATE

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:9884233

object_name: Adverse drug response


subject: CHEBI:2549

subject_name: Albuterol


subject: CHEBI:2549


subject: CHEBI:4670

subject_name: Dobutamine


subject: CHEBI:180905

subject_name: Nicardipine


subject: CHEBI:180905


subject: CHEBI:8081

subject_name: Phentolamine


subject: CHEBI:8081


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:53188

subject_name: verapamil hydrochloride


subject: CHEBI:53188


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: PUBCHEM.COMPOUND:13006297

subject_name: Sodium copper chlorophyllin

object_name: hemorrhagic cystitis


subject: UNII:1D276TYV9O

subject_name: SODIUM COPPER CHLOROPHYLLIN


subject: UNII:EEM82VOY7C

subject_name: chlorophyllin


subject: GTOPDB:10492

subject_name: envafolimab

object_name: Locally Advanced Rectal Carcinoma


subject: GTOPDB:10492

object_name: MSI-high


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: CHEBI:2955

subject_name: Azithromycin

object_name: classic familial adenomatous polyposis


subject: CHEBI:2955

object_name: Adenomatous colonic polyposis


subject: CHEBI:17632

subject_name: Nitrate

object_name: cardio-renal syndrome


subject: CHEBI:6061

subject_name: Isosorbide dinitrate


subject: CHEBI:39585

subject_name: Carbidopa

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:48947

subject_name: Clavulanic acid

object_name: respiratory tract infectious disorder


subject: UMLS:C1136177

subject_name: Sirtuins

object_name: Unresectable Hepatocellular Carcinoma


subject: UMLS:C0596581

subject_name: Fluoropyrimidine

object_name: rectum adenocarcinoma


subject: CHEBI:2453

subject_name: Acyclovir

object_name: herpes simplex virus keratitis


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: malignant soft tissue neoplasm


subject: UMLS:C0392939

object_name: sarcoma


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: pustulosis palmaris et plantaris


subject: UMLS:C4078397


subject: CHEMBL.COMPOUND:CHEMBL1237024

subject_name: SIPULEUCEL-T

object_name: Metastatic malignant neoplasm to bone


subject: CHEMBL.COMPOUND:CHEMBL1237024

object_name: Metastatic malignant neoplasm to soft tissues


subject: UMLS:C5446585

subject_name: Emidurdar

object_name: metastatic colorectal cancer


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Delayed Emergence from Anesthesia


subject: CHEBI:3347

subject_name: Candesartan

object_name: traumatic brain injury


subject: PUBCHEM.COMPOUND:54751657

subject_name: Minocin

object_name: traumatic encephalopathy


subject: PUBCHEM.COMPOUND:54751657


subject: CHEBI:50697

subject_name: minocycline hydrochloride


subject: CHEBI:50697


subject: UMLS:C3248648

subject_name: Injection, minocycline hydrochloride, 1 mg administered


subject: UMLS:C3248648


subject: CHEBI:37845

subject_name: growth hormone

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:72296

subject_name: Apixaban

object_name: Leg Injuries


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: MESH:C000721066

object_name: influenza


subject: CHEBI:30762

subject_name: salicylate

object_name: Heloma


subject: CHEBI:9008

subject_name: salicylurate


subject: CHEBI:16914

subject_name: Salicylic acid


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:52717

object_name: myoclonic dystonia 11


subject: CHEBI:90225

subject_name: Rubitecan

object_name: Childhood Breast Carcinoma


subject: CHEBI:90225

object_name: breast carcinoma


subject: CHEBI:90225

object_name: breast cancer


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: impotence


subject: CHEBI:61057

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:61057

object_name: Erectile dysfunction


subject: CHEBI:61057

object_name: prostate carcinoma


subject: CHEBI:61057

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:3509

object_name: Pseudomonas aeruginosa infection


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: CHEBI:59004

subject_name: Hypericum

object_name: Depressed mood


subject: CHEBI:59004

object_name: Cancer patients and suicide and depression


subject: CHEBI:59004

object_name: Depressed - symptom


subject: CHEBI:59004

object_name: Depression, CTCAE


subject: UMLS:C1706292

subject_name: Hypericum extract


subject: UMLS:C1706292


subject: UMLS:C1706292


subject: UMLS:C1706292


subject: UMLS:C4745318

subject_name: CXA 201

object_name: pyelonephritis


subject: UMLS:C4745318

object_name: Complicated urinary tract infection


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: cancer


subject: PUBCHEM.COMPOUND:91826462

object_name: neoplasm


subject: GTOPDB:9589

subject_name: enoblituzumab

object_name: melanoma


subject: GTOPDB:9589

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545373

subject_name: ENOBLITUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: UMLS:C0013230

subject_name: Investigational New Drugs


subject: UMLS:C0013230

object_name: lung neoplasm


subject: UMLS:C0701858

subject_name: Antiperspirants

object_name: hand-foot syndrome


subject: UMLS:C5139894

subject_name: gimsilumab

object_name: rheumatoid arthritis


subject: UMLS:C5784742

subject_name: Anti-FRa ADC IMGN151

object_name: female reproductive organ cancer


subject: UMLS:C5784742

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: DRUGBANK:DB17976

object_name: Parkinson disease


subject: DRUGBANK:DB17976

object_name: neurodegenerative disease


subject: CHEBI:48273

subject_name: Rizatriptan

object_name: Episodic migraine


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:50730

subject_name: Montelukast


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: UMLS:C0388976

subject_name: Ecteinascidin 743


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Acute rejection of renal transplant


subject: CHEBI:3441

subject_name: Carvedilol

object_name: chronic obstructive pulmonary disease


subject: CHEBI:74701

subject_name: Met-Gln

object_name: malaria


subject: UMLS:C1186762

subject_name: Dakins Solution

object_name: radiodermatitis


subject: UMLS:C1186762

object_name: Neck Carcinoma


subject: CHEBI:135544

subject_name: Ilaprazole

object_name: Helicobacter pylori infectious disease


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: carcinoma


subject: UNII:2285XW22DR

object_name: neuroendocrine neoplasm


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: MESH:C030396

object_name: Fracture of shaft of femur


subject: UMLS:C1436435

subject_name: NTZ

object_name: hepatitis C


subject: UMLS:C1436435

object_name: HIV infection


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Hypothermia due to exposure


subject: CHEBI:6887

object_name: Hypothermia


subject: CHEBI:6887

object_name: Hypothermia, CTCAE


subject: CHEBI:6887

object_name: exercise test


subject: UMLS:C5447553

subject_name: CD200 Activation Receptor Ligand hP1A8

object_name: glioblastoma


subject: UMLS:C5447553

object_name: Childhood Glioblastoma


subject: UMLS:C5447553

object_name: adult glioblastoma


subject: UMLS:C2348275

subject_name: Dietary Nitrate

object_name: cardiomyopathy


subject: UMLS:C4722737

subject_name: AXS 05

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: rosacea


subject: UMLS:C1170024

subject_name: Adderall-XR

object_name: Cannabis use disorder


subject: UMLS:C4053661

subject_name: mTORC1/2 Kinase Inhibitor BI 860585

object_name: neoplasm


subject: PUBCHEM.COMPOUND:166822065

object_name: vascular malformation


subject: PUBCHEM.COMPOUND:166822065

object_name: lymphatic malformation


subject: PUBCHEM.COMPOUND:166822065

object_name: angioosteohypertrophic syndrome


subject: PUBCHEM.COMPOUND:166822065

object_name: CLOVES syndrome


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: UMLS:C2713112

object_name: actinic keratosis


subject: UMLS:C4048796

object_name: Basal cell carcinoma in basal cell nevus syndrome


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid

object_name: amyloid; cardiomyopathy (etiology)


subject: CHEBI:80774

subject_name: taurursodiol


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UMLS:C5205493

subject_name: Pucotenlimab

object_name: Adult Penile Carcinoma


subject: UMLS:C5205493

object_name: penis carcinoma


subject: UMLS:C5205493

object_name: penile cancer


subject: UMLS:C5556477


subject: UMLS:C5556477


subject: UMLS:C5556477


subject: CHEBI:82975

subject_name: Naloxegol

object_name: gastroparesis


subject: CHEBI:82975

object_name: Gastroparesis, CTCAE


subject: CHEBI:82975

object_name: opioid use


subject: UMLS:C3661059

object_name: hypertension


subject: UMLS:C3661059

object_name: Hypertension, CTCAE


subject: CHEBI:149601

subject_name: Bempedoic acid


subject: CHEBI:149601


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: nasopharyngeal carcinoma


subject: UNII:B2K5L1L8S9

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C3896841


subject: UMLS:C3896841


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage III Lung Cancer


subject: UMLS:C4329335

subject_name: IBI 308


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:9014

subject_name: Salsalate

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:9014

object_name: acute myeloid leukemia


subject: CHEBI:9014

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:9014

object_name: myeloproliferative neoplasm


subject: CHEBI:9014

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:9014

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:9014

object_name: Refractory acute myeloid leukemia


subject: CHEBI:9014

object_name: Myelodysplasia


subject: CHEBI:9014

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:9014

object_name: childhood myelodysplastic syndrome


subject: CHEBI:9014

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:9014

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:9014

object_name: chronic myelomonocytic leukemia


subject: CHEBI:9014


subject: CHEBI:133021

subject_name: Venetoclax


subject: UMLS:C5556424

subject_name: Lumrotatug

object_name: pemphigus vulgaris


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: CHEBI:143658

object_name: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C0308804

subject_name: Dexamethasone Sodium Phosphate Injection

object_name: retinal detachment


subject: UMLS:C0308804

object_name: Retinal Detachment, CTCAE 3.0


subject: UMLS:C0308804

object_name: Retinal Detachment, CTCAE 5.0


subject: MESH:D007166

subject_name: Immunosuppressive Agents

object_name: infertility


subject: CHEBI:18258

subject_name: Liothyronine

object_name: multiple sclerosis


subject: UMLS:C0010826

subject_name: Cytomel


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Recurrent Laryngeal Nerve Injuries


subject: CHEBI:6456

object_name: Accessory Nerve Injuries


subject: CHEBI:6456

object_name: EMG: repetitive nerve stimulation abnormality


subject: CHEBI:6456

object_name: Cancer of Neck


subject: CHEBI:10102

subject_name: Zaleplon

object_name: Memory observations


subject: CHEBI:3139

subject_name: bleomycin

object_name: common wart


subject: UMLS:C0034131

subject_name: Tubersol


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Postoperative delirium


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: endometrial cancer


subject: CHEBI:4903

object_name: uterine corpus cancer


subject: CHEBI:4903

object_name: endometrial carcinoma


subject: CHEBI:74705

subject_name: Met-Leu

object_name: heart valve disorder


subject: CHEBI:74705

object_name: Valvular Heart Disease, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Anaplastic Kidney Wilms Tumor


subject: CHEBI:31355

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816

object_name: Stage II Kidney Wilms Tumor


subject: CHEBI:64816

object_name: Stage III Kidney Wilms Tumor


subject: CHEBI:64816

object_name: Stage IV Kidney Wilms Tumor


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: UMLS:C0796512

subject_name: CCI 779

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C0796512

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C0796512

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C0796512

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0796512

object_name: clear cell renal carcinoma


subject: UMLS:C0796512

object_name: Renal cell carcinoma recurrent


subject: UMLS:C0796512

object_name: Renal cancer recurrent


subject: MESH:C581747

subject_name: uromune

object_name: urinary tract infection


subject: MESH:C581747

object_name: Chronic urinary tract infection


subject: MESH:C581747

object_name: bacterial urinary tract infection


subject: MESH:C581747

object_name: Infective cystitis


subject: MESH:C581747

object_name: cystitis


subject: MESH:C581747

object_name: Bladder Infection, CTCAE


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: perinatal necrotizing enterocolitis


subject: CHEBI:7986

object_name: necrotizing enterocolitis


subject: CHEBI:7986

object_name: Necrotizing Enterocolitis, AE


subject: UMLS:C3485429

subject_name: Probiotic Formula


subject: UMLS:C3485429


subject: UMLS:C3485429


subject: CHEBI:36791

subject_name: Escitalopram

object_name: functional gastric disease


subject: CHEBI:3723

subject_name: Citalopram


subject: UMLS:C0016018

subject_name: Fibrinolytic Agents

object_name: Acute Ischemic Stroke


subject: UMLS:C0016018

object_name: Ischemic stroke


subject: UMLS:C3536865

subject_name: Thrombolytic Agent [EPC]


subject: UMLS:C3536865


subject: CHEBI:17968

subject_name: butyrate

object_name: radiation proctitis


subject: MESH:D002087

subject_name: Butyrates


subject: CHEBI:30772

subject_name: Butyric Acid


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: HIV-1 infection


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:174428


subject: CHEBI:15414

subject_name: Adomet


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:177406

subject_name: CDDO-Me

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:53315588


subject: CHEBI:73422

subject_name: Asn-Gly

object_name: Antibodies drug specific


subject: CHEBI:73422

object_name: diabetes mellitus


subject: CHEBI:21759

subject_name: N-methyl-N'-nitro-N-nitrosoguanidine


subject: CHEBI:21759


subject: CHEBI:28787

subject_name: Nitroglycerin


subject: CHEBI:28787


subject: PR:000011426

subject_name: neurogranin


subject: PR:000011426


subject: CHEBI:75551

object_name: arteriosclerosis disorder


subject: CHEBI:75551

object_name: atherosclerosis


subject: CHEBI:233197

subject_name: devimistat

object_name: leukemia


subject: CHEBI:233197

object_name: childhood leukemia


subject: UMLS:C2703200

subject_name: CPI 613


subject: UMLS:C2703200


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:91414

object_name: Recurrent Glioblastoma


subject: UMLS:C1328072

subject_name: Recombinant Vaccinia-MUC-1 Vaccine

object_name: male breast carcinoma


subject: UMLS:C1328072

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C1328072

object_name: Carcinoma breast stage IV


subject: UMLS:C1328072

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1328072

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1328072

object_name: Breast cancer recurrent


subject: MESH:C439566

subject_name: rV-Tricom


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: MESH:C439566


subject: UMLS:C2745432

subject_name: Meditoxin

object_name: masticatory muscles, hypertrophy of


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: sarcopenia


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UNII:795J01AE70

subject_name: DEXPRAMIPEXOLE DIHYDROCHLORIDE

object_name: asthma


subject: UMLS:C5238200

subject_name: Dexpramipexole Dihydrochloride


subject: CHEBI:33349

subject_name: dubnium atom

object_name: euthyroid Graves orbitopathy


subject: CHEBI:33349

object_name: endocrine exophthalmos


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:33357


subject: CHEBI:133630

subject_name: His-Ala


subject: CHEBI:133630


subject: UniProtKB:P03456

subject_name: HEMA_I68A3 Hemagglutinin (sprot)


subject: UniProtKB:P03456


subject: UniProtKB:P03446

subject_name: HEMA_I76A2 Hemagglutinin (sprot)


subject: UniProtKB:P03446


subject: UniProtKB:A3DRP0

subject_name: HEMA_I96A2 Hemagglutinin (sprot)


subject: UniProtKB:A3DRP0


subject: UniProtKB:A4K143

subject_name: HEMA_I54A2 Hemagglutinin (sprot)


subject: UniProtKB:A4K143


subject: UniProtKB:B4URD6

subject_name: HEMA_I06A0 Hemagglutinin (sprot)


subject: UniProtKB:B4URD6


subject: UniProtKB:Q0A448

subject_name: hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


subject: UniProtKB:Q0A448


subject: UMLS:C4285347

subject_name: Ha Antibody


subject: UMLS:C4285347


subject: UniProtKB:Q9WCD8

subject_name: HEMA_I61A1 Hemagglutinin (sprot)


subject: UniProtKB:Q9WCD8


subject: UniProtKB:P03453

subject_name: HEMA_I77AB Hemagglutinin (sprot)


subject: UniProtKB:P03453


subject: UniProtKB:A4U7A6

subject_name: HEMA_I51A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U7A6


subject: UniProtKB:P13103

subject_name: HEMA_I77AF Hemagglutinin (sprot)


subject: UniProtKB:P13103


subject: UniProtKB:P26136

subject_name: HEMA_I82A1 Hemagglutinin (sprot)


subject: UniProtKB:P26136


subject: UniProtKB:P07976

subject_name: HEMA_I83A5 Hemagglutinin (sprot)


subject: UniProtKB:P07976


subject: UniProtKB:A4GBX7

subject_name: HEMA_I77AA Hemagglutinin (sprot)


subject: UniProtKB:A4GBX7


subject: UniProtKB:P19698

subject_name: HEMA_I79A7 Hemagglutinin (sprot)


subject: UniProtKB:P19698


subject: UniProtKB:Q6LEJ4

subject_name: HEMA_I80A2 Hemagglutinin (sprot)


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:P03457

subject_name: HEMA_I66A1 Hemagglutinin (sprot)


subject: UniProtKB:P03457


subject: UniProtKB:A4GCL9

subject_name: HEMA_I35A3 Hemagglutinin (sprot)


subject: UniProtKB:A4GCL9


subject: UniProtKB:Q9WFX3

subject_name: HEMA_I18A0 Hemagglutinin (sprot)


subject: UniProtKB:Q9WFX3


subject: UniProtKB:A4U6V2

subject_name: HEMA_I45A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U6V2


subject: UniProtKB:Q07FI5

subject_name: HEMA_I96A3 Hemagglutinin (sprot)


subject: UniProtKB:Q07FI5


subject: UniProtKB:P03454

subject_name: HEMA_I33A0 Hemagglutinin (sprot)


subject: UniProtKB:P03454


subject: UniProtKB:A4GCK8

subject_name: HEMA_I43A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCK8


subject: UniProtKB:P03448

subject_name: HEMA_I72A5 Hemagglutinin (sprot)


subject: UniProtKB:P03448


subject: UniProtKB:A4GCI6

subject_name: HEMA_I36A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCJ7

subject_name: HEMA_I80AA Hemagglutinin (sprot)


subject: UniProtKB:A4GCJ7


subject: UniProtKB:P04661

subject_name: HEMA_I56A2 Hemagglutinin (sprot)


subject: UniProtKB:P04661


subject: UniProtKB:Q0HD60

subject_name: HEMA_I40A0 Hemagglutinin (sprot)


subject: UniProtKB:Q0HD60


subject: UniProtKB:P26139

subject_name: HEMA_I77A4 Hemagglutinin (sprot)


subject: UniProtKB:P26139


subject: UniProtKB:A4GCH5

subject_name: HEMA_I83A1 Hemagglutinin (sprot)


subject: UniProtKB:A4GCH5


subject: CHEBI:201756

subject_name: Clindamycin 2-Phosphate

object_name: glioblastoma


subject: CHEBI:201756

object_name: Childhood Glioblastoma


subject: CHEBI:201756

object_name: adult glioblastoma


subject: CHEBI:201756

object_name: Skin toxicity


subject: CHEBI:201756

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:201756

object_name: Recurrent Glioblastoma


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:3745


subject: CHEBI:3745


subject: CHEBI:3745


subject: CHEBI:3745


subject: CHEBI:3745


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: UNII:W6F4FRQ5QC

subject_name: PULRODEMSTAT

object_name: prostate cancer


subject: UNII:W6F4FRQ5QC

object_name: prostate neoplasm


subject: UMLS:C4330526


subject: UMLS:C4330526


subject: CHEBI:59728

subject_name: desmopressin acetate trihydrate

object_name: Nocturia


subject: CHEBI:59726

subject_name: desmopressin acetate (anhydrous)


subject: UMLS:C0086135

subject_name: DDAVP


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: chronic eosinophilic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: chronic neutrophilic leukemia


subject: PUBCHEM.COMPOUND:596

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:596

object_name: essential thrombocythemia


subject: PUBCHEM.COMPOUND:596

object_name: acquired polycythemia vera


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:4911

object_name: Adult Acute Promyelocytic Leukemia


subject: CHEBI:4911

object_name: chronic myelomonocytic leukemia


subject: CHEBI:4911

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4911

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911

object_name: myelofibrosis


subject: CHEBI:45716

subject_name: Vorinostat

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:45716

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:45716

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Acute illness


subject: CHEBI:15927

object_name: Inflammation


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Confusion, CTCAE 3.0


subject: UMLS:C1527137

object_name: Bewilderment


subject: UMLS:C1527137

object_name: Confusion, CTCAE 5.0


subject: UMLS:C1527137

object_name: Confusion


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Flail Chest


subject: CHEBI:17303

subject_name: Morphine


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:9667


subject: UNII:S3F315JJXI


subject: CHEBI:4893

subject_name: ethyl acetoacetate

object_name: military operational stress reaction


subject: CHEBI:4893

object_name: Malnutrition (calorie)


subject: CHEBI:4893

object_name: Weight loss


subject: CHEBI:4893

object_name: Weight Loss, CTCAE


subject: UMLS:C0243046

subject_name: Excitatory Amino Acids


subject: UMLS:C0243046


subject: UMLS:C0243046


subject: UMLS:C0243046


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Polyuria


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:51052

subject_name: Lucanthone

object_name: glioblastoma


subject: CHEBI:51052

object_name: Brain Stem Glioblastoma


subject: CHEBI:51052

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: strabismus


subject: CHEBI:3215

object_name: strabismus on exam (physical finding)


subject: CHEBI:3215

object_name: ptosis


subject: CHEBI:3215

object_name: esotropia


subject: CHEBI:3215

object_name: exotropia


subject: CHEBI:145499

subject_name: Donepezil

object_name: Wound healed (finding)


subject: CHEMBL.COMPOUND:CHEMBL4802180

subject_name: RECOMBINANT HUMAN THROMBOPOIETIN

object_name: thrombocytopenia


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Neck pain


subject: CHEBI:46195

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:46195

object_name: Neck Pain, CTCAE 3.0


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: metastatic colorectal cancer


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: fibrosis


subject: CHEBI:68841

object_name: kidney failure


subject: UMLS:C0388020

subject_name: Gadovist


subject: UMLS:C0388020


subject: UMLS:C2713023


subject: UMLS:C2713023


subject: UNII:63P236Z73I

object_name: Female sexual dysfunction


subject: UMLS:C5418050

subject_name: DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5418050

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5418050

object_name: B-cell neoplasm


subject: MESH:C000728624


subject: UMLS:C4329438


subject: UNII:W525NLS74J

object_name: intracerebral hemorrhage


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: secondary progressive multiple sclerosis


subject: CHEBI:5893

subject_name: Indapamide


subject: PUBCHEM.COMPOUND:68952594

subject_name: Avenanthramidec

object_name: Inflammation


subject: CHEBI:185306


subject: UMLS:C5136796

subject_name: AVENANTHRAMIDES


subject: PUBCHEM.COMPOUND:11539381

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:11539381

object_name: hyperlipoproteinemia


subject: PUBCHEM.COMPOUND:11539381

object_name: Hyperlipidemia, CTCAE


subject: PUBCHEM.COMPOUND:11539381

object_name: Serum lipids high (finding)


subject: UMLS:C3492258


subject: UMLS:C3492258


subject: UMLS:C3492258


subject: UMLS:C3492258


subject: CHEMBL.COMPOUND:CHEMBL4297577

subject_name: BELAPECTIN

object_name: Cirrhosis


subject: CHEMBL.COMPOUND:CHEMBL4297577

object_name: liver cirrhosis


subject: CHEMBL.COMPOUND:CHEMBL4297577


subject: CHEBI:6801

subject_name: Metformin

object_name: Hypoxemia


subject: CHEBI:6801

object_name: Hypoxia, CTCAE


subject: CHEBI:82975

subject_name: Naloxegol

object_name: cancer


subject: CHEBI:82975

object_name: neoplasm


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Gaucher disease


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: adult germ cell tumor


subject: UNII:7XL5ISS668

object_name: childhood germ cell tumor


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C4266448


subject: UMLS:C4266448


subject: CHEBI:68841


subject: CHEBI:68841


subject: UNII:9430ZR8ZAN

subject_name: gadofosveset


subject: UNII:9430ZR8ZAN


subject: CHEBI:31797

subject_name: Gadolinium DTPA


subject: CHEBI:31797


subject: CHEBI:180856

subject_name: Hovenoside G


subject: CHEBI:180856


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: bacteriuria


subject: CHEBI:3770

object_name: Perioperative complication


subject: CHEBI:3770

object_name: prostate carcinoma


subject: CHEBI:3770

object_name: prostate cancer


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UNII:KXQ762CQTH

object_name: Ovarian clear cell carcinoma


subject: UNII:KXQ762CQTH

object_name: ovarian clear cell cancer


subject: UNII:J6U9WP10T7


subject: UNII:J6U9WP10T7


subject: UMLS:C0310589

subject_name: Vitamins A and D preparation

object_name: Iron deficiency


subject: UMLS:C0310589

object_name: iron deficiency anemia


subject: CHEBI:74947

subject_name: Thalidomide

object_name: colorectal cancer


subject: CHEBI:74947

object_name: colorectal carcinoma


subject: CHEBI:74947

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Head and neck cancer stage III


subject: CHEBI:3207

subject_name: Budesonide

object_name: acute chest syndrome


subject: CHEBI:3207

object_name: sickle cell disease


subject: CHEBI:82977

subject_name: Daclatasvir

object_name: HIV infection


subject: CHEBI:82977

object_name: hepatitis C virus, susceptibility to


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A

object_name: Congenital postural scoliosis


subject: PUBCHEM.COMPOUND:56841986

object_name: scoliosis


subject: PUBCHEM.COMPOUND:56841986

object_name: Scoliosis, CTCAE


subject: PUBCHEM.COMPOUND:56841986

object_name: acute kidney failure


subject: PUBCHEM.COMPOUND:56841986

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:6456

subject_name: Lidocaine

object_name: myofascial pain syndrome


subject: CHEBI:25812

subject_name: Ozone


subject: CHEBI:25812

object_name: fibromyalgia


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Hypercholesterolemia


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: UNII:09J8QNB0L9

subject_name: CRYOPRECIPITATE

object_name: Acquired fibrinogen deficiency


subject: UMLS:C0443121

subject_name: Cryoprecipitate (product)


subject: UMLS:C5553020

subject_name: Cryoprecipitated Plasma


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: acute lung injury


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: head and neck squamous cell carcinoma


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Blood Pressure Disorders


subject: CHEBI:40279

object_name: excess; salt